BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 7 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 9 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 10 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 21 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 22 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 7 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 9 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 10 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 21 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 22 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 day ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago
ADVERTISEMENT
AlphaGraphs

PFE Earnings: All you need to know about Pfizer’s Q1 2023 earnings results

Pfizer Inc. (NYSE: PFE) reported first quarter 2023 earnings results today. Revenues declined 29% year-over-year to $18.3 billion. Reported net income fell 30% to $5.5 billion, or $0.97 per share, compared to last year. Adjusted EPS was down 24% to $1.23. Both revenue and earnings beat estimates. For the full year of 2023, Pfizer expects […]

May 2, 2023 1 min read

Pfizer Inc. (NYSE: PFE) reported first quarter 2023 earnings results today.

Revenues declined 29% year-over-year to $18.3 billion.

Reported net income fell 30% to $5.5 billion, or $0.97 per share, compared to last year. Adjusted EPS was down 24% to $1.23.

Both revenue and earnings beat estimates.

For the full year of 2023, Pfizer expects revenue of $67-71 billion.

ADVERTISEMENT

Prior performance

Pfizer-Q4-2022-Earnings-Infographic
ADVERTISEMENT